(4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide

C32H41BrI2N6O5S2 — CID 53325054

IUPAC(4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide
SMILESCSc1c2sc(C3=C(C(=O)O)N4C(=O)[C@H]([C@@H](C)O)[C@H]4[C@H]3C)cn2c[n+]1Cc1cccc(C[N+]23CC[N+](CC(N)=O)(CC2)CC3)c1.[Br-].[I-].[I-]
InChIInChI=1S/C32H39N6O5S2.BrH.2HI/c1-19-25(28(32(42)43)36-27(19)26(20(2)39)29(36)41)23-15-35-18-34(30(44-3)31(35)45-23)14-21-5-4-6-22(13-21)16-37-7-10-38(11-8-37,12-9-37)17-24(33)40;;;/h4-6,13,15,18-20,26-27,39H,7-12,14,16-17H2,1-3H3,(H-2,33,40,42,43);3*1H/q+1;;;/p-1/t19-,20+,26+,27+,37?,38?;;;/m0.../s1
InChIKeyLFCNUDRMLSDZDA-JBFGNUOGSA-M
MW987.56 g/mol
LogP-7.63
Rot. Bonds10

About (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide

(4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide (PubChem CID 53325054) has the molecular formula C32H41BrI2N6O5S2 and a molecular weight of 987.56 g/mol. Its IUPAC name is (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide.

Molecular Properties

Compound Name(4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide
PubChem CID53325054
Molecular FormulaC32H41BrI2N6O5S2
Molecular Weight987.56 g/mol
Exact Mass985.99
IUPAC Name(4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide
SMILESCSc1c2sc(C3=C(C(=O)O)N4C(=O)[C@H]([C@@H](C)O)[C@H]4[C@H]3C)cn2c[n+]1Cc1cccc(C[N+]23CC[N+](CC(N)=O)(CC2)CC3)c1.[Br-].[I-].[I-]
InChIInChI=1S/C32H39N6O5S2.BrH.2HI/c1-19-25(28(32(42)43)36-27(19)26(20(2)39)29(36)41)23-15-35-18-34(30(44-3)31(35)45-23)14-21-5-4-6-22(13-21)16-37-7-10-38(11-8-37,12-9-37)17-24(33)40;;;/h4-6,13,15,18-20,26-27,39H,7-12,14,16-17H2,1-3H3,(H-2,33,40,42,43);3*1H/q+1;;;/p-1/t19-,20+,26+,27+,37?,38?;;;/m0.../s1
InChIKeyLFCNUDRMLSDZDA-JBFGNUOGSA-M
XLogP-7.63
TPSA129.22 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds10
Heavy Atoms48
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500987.56
LogP ≤ 5-7.63
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide?
The IUPAC name of (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide (CID 53325054) is (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide.
What is the SMILES notation for (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide?
The canonical SMILES for (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide is CSc1c2sc(C3=C(C(=O)O)N4C(=O)[C@H]([C@@H](C)O)[C@H]4[C@H]3C)cn2c[n+]1Cc1cccc(C[N+]23CC[N+](CC(N)=O)(CC2)CC3)c1.[Br-].[I-].[I-].
What is the InChIKey of (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide?
The InChIKey is LFCNUDRMLSDZDA-JBFGNUOGSA-M. The full InChI is InChI=1S/C32H39N6O5S2.BrH.2HI/c1-19-25(28(32(42)43)36-27(19)26(20(2)39)29(36)41)23-15-35-18-34(30(44-3)31(35)45-23)14-21-5-4-6-22(13-21)16-37-7-10-38(11-8-37,12-9-37)17-24(33)40;;;/h4-6,13,15,18-20,26-27,39H,7-12,14,16-17H2,1-3H3,(H-2,33,40,42,43);3*1H/q+1;;;/p-1/t19-,20+,26+,27+,37?,38?;;;/m0.../s1.
What are the key properties of (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide?
(4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide has a molecular weight of 987.56 g/mol, XLogP of -7.63, 10 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,5R,6S)-3-[6-[[3-[[4-(2-amino-2-oxoethyl)-1,4-diazoniabicyclo[2.2.2]octan-1-yl]methyl]phenyl]methyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;bromide;diiodide is sourced from PubChem (CID 53325054), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).